These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16481971)

  • 1. Cyclic treatment of chronic hepatic encephalopathy with rifaximin. Results of a double-blind clinical study.
    Loguercio C; Federico A; De Girolamo V; Ferrieri A; Del Vecchio Blanco C
    Minerva Gastroenterol Dietol; 2003 Mar; 49(1):53-62. PubMed ID: 16481971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
    Ahire K; Sonawale A
    J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
    Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.
    Gheorghe L; Iacob R; Vădan R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2005 Sep; 14(3):231-8. PubMed ID: 16200232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension.
    Kundra A; Jain A; Banga A; Bajaj G; Kar P
    Clin Biochem; 2005 Aug; 38(8):696-9. PubMed ID: 15963970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.
    Mas A; Rodés J; Sunyer L; Rodrigo L; Planas R; Vargas V; Castells L; Rodríguez-Martínez D; Fernández-Rodríguez C; Coll I; Pardo A;
    J Hepatol; 2003 Jan; 38(1):51-8. PubMed ID: 12480560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study.
    Pai CH; Huang YS; Jeng WC; Chan CY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):31-6. PubMed ID: 7712392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations on the impact of hepatic encephalopathy treatments in the pretransplant setting.
    Teperman LW; Peyregne VP
    Transplantation; 2010 Apr; 89(7):771-8. PubMed ID: 20110852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial.
    Uribe M; Toledo H; Perez F; Vargas F; Gil S; Garcia-Ramos G; Ravelli GP; Guevara L
    Dig Dis Sci; 1987 Dec; 32(12):1345-53. PubMed ID: 3319453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients.
    Castillejo G; Bulló M; Anguera A; Escribano J; Salas-Salvadó J
    Pediatrics; 2006 Sep; 118(3):e641-8. PubMed ID: 16950955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan.
    Chang C; Huang CH; Tseng HJ; Yang FC; Chien RN
    J Pers Med; 2021 May; 11(6):. PubMed ID: 34071787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of hepatic myelopathy in patients with chronic liver disease.
    Yin YH; Ma ZJ; Guan YH; Ren YD; Zhang ZL
    Postgrad Med J; 2009 Feb; 85(1000):64-8. PubMed ID: 19329698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
    Kalaitzakis E; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Jalan R; Björnsson E
    Liver Int; 2007 Nov; 27(9):1194-201. PubMed ID: 17919230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
    Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.